Cargando…

The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness

BACKGROUND: CRF02_AG is the predominant HIV strain circulating in West and West Central Africa. The aim of this study was to test whether this predominance is associated with a higher in vitro replicative fitness relative to parental subtype A and G viruses. Primary HIV-1 isolates (10 CRF02_AG, 5 su...

Descripción completa

Detalles Bibliográficos
Autores principales: Njai, Harr F, Gali, Youssef, Vanham, Guido, Clybergh, Claude, Jennes, Wim, Vidal, Nicole, Butel, Christelle, Mpoudi-Ngolle, Eitel, Peeters, Martine, Ariën, Kevin K
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1525194/
https://www.ncbi.nlm.nih.gov/pubmed/16817969
http://dx.doi.org/10.1186/1742-4690-3-40
_version_ 1782128884832010240
author Njai, Harr F
Gali, Youssef
Vanham, Guido
Clybergh, Claude
Jennes, Wim
Vidal, Nicole
Butel, Christelle
Mpoudi-Ngolle, Eitel
Peeters, Martine
Ariën, Kevin K
author_facet Njai, Harr F
Gali, Youssef
Vanham, Guido
Clybergh, Claude
Jennes, Wim
Vidal, Nicole
Butel, Christelle
Mpoudi-Ngolle, Eitel
Peeters, Martine
Ariën, Kevin K
author_sort Njai, Harr F
collection PubMed
description BACKGROUND: CRF02_AG is the predominant HIV strain circulating in West and West Central Africa. The aim of this study was to test whether this predominance is associated with a higher in vitro replicative fitness relative to parental subtype A and G viruses. Primary HIV-1 isolates (10 CRF02_AG, 5 subtype A and 5 subtype G) were obtained from a well-described Cameroonian cohort. Growth competition experiments were carried out at equal multiplicity of infection in activated T cells and monocyte-derived dendritic cells (MO-DC) in parallel. RESULTS: Dual infection/competition experiments in activated T cells clearly indicated that CRF02_AG isolates had a significant replication advantage over the subtype A and subtype G viruses. The higher fitness of CRF02_AG was evident for isolates from patients with CD4+ T cell counts >200 cells/μL (non-AIDS) or CD4+ T cell counts <200 cells/μL (AIDS), and was independent of the co-receptor tropism. In MO-DC cultures, CRF02_AG isolates showed a slightly but not significantly higher replication advantage compared to subtype A or G isolates. CONCLUSION: We observed a higher ex vivo replicative fitness of CRF02_AG isolates compared to subtype A and G viruses from the same geographic region and showed that this was independent of the co-receptor tropism and irrespective of high or low CD4+ T cell count. This advantage in replicative fitness may contribute to the dominant spread of CRF02_AG over A and G subtypes in West and West Central Africa.
format Text
id pubmed-1525194
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-15251942006-08-02 The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness Njai, Harr F Gali, Youssef Vanham, Guido Clybergh, Claude Jennes, Wim Vidal, Nicole Butel, Christelle Mpoudi-Ngolle, Eitel Peeters, Martine Ariën, Kevin K Retrovirology Research BACKGROUND: CRF02_AG is the predominant HIV strain circulating in West and West Central Africa. The aim of this study was to test whether this predominance is associated with a higher in vitro replicative fitness relative to parental subtype A and G viruses. Primary HIV-1 isolates (10 CRF02_AG, 5 subtype A and 5 subtype G) were obtained from a well-described Cameroonian cohort. Growth competition experiments were carried out at equal multiplicity of infection in activated T cells and monocyte-derived dendritic cells (MO-DC) in parallel. RESULTS: Dual infection/competition experiments in activated T cells clearly indicated that CRF02_AG isolates had a significant replication advantage over the subtype A and subtype G viruses. The higher fitness of CRF02_AG was evident for isolates from patients with CD4+ T cell counts >200 cells/μL (non-AIDS) or CD4+ T cell counts <200 cells/μL (AIDS), and was independent of the co-receptor tropism. In MO-DC cultures, CRF02_AG isolates showed a slightly but not significantly higher replication advantage compared to subtype A or G isolates. CONCLUSION: We observed a higher ex vivo replicative fitness of CRF02_AG isolates compared to subtype A and G viruses from the same geographic region and showed that this was independent of the co-receptor tropism and irrespective of high or low CD4+ T cell count. This advantage in replicative fitness may contribute to the dominant spread of CRF02_AG over A and G subtypes in West and West Central Africa. BioMed Central 2006-07-03 /pmc/articles/PMC1525194/ /pubmed/16817969 http://dx.doi.org/10.1186/1742-4690-3-40 Text en Copyright © 2006 Njai et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Njai, Harr F
Gali, Youssef
Vanham, Guido
Clybergh, Claude
Jennes, Wim
Vidal, Nicole
Butel, Christelle
Mpoudi-Ngolle, Eitel
Peeters, Martine
Ariën, Kevin K
The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness
title The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness
title_full The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness
title_fullStr The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness
title_full_unstemmed The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness
title_short The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness
title_sort predominance of human immunodeficiency virus type 1 (hiv-1) circulating recombinant form 02 (crf02_ag) in west central africa may be related to its replicative fitness
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1525194/
https://www.ncbi.nlm.nih.gov/pubmed/16817969
http://dx.doi.org/10.1186/1742-4690-3-40
work_keys_str_mv AT njaiharrf thepredominanceofhumanimmunodeficiencyvirustype1hiv1circulatingrecombinantform02crf02aginwestcentralafricamayberelatedtoitsreplicativefitness
AT galiyoussef thepredominanceofhumanimmunodeficiencyvirustype1hiv1circulatingrecombinantform02crf02aginwestcentralafricamayberelatedtoitsreplicativefitness
AT vanhamguido thepredominanceofhumanimmunodeficiencyvirustype1hiv1circulatingrecombinantform02crf02aginwestcentralafricamayberelatedtoitsreplicativefitness
AT clyberghclaude thepredominanceofhumanimmunodeficiencyvirustype1hiv1circulatingrecombinantform02crf02aginwestcentralafricamayberelatedtoitsreplicativefitness
AT jenneswim thepredominanceofhumanimmunodeficiencyvirustype1hiv1circulatingrecombinantform02crf02aginwestcentralafricamayberelatedtoitsreplicativefitness
AT vidalnicole thepredominanceofhumanimmunodeficiencyvirustype1hiv1circulatingrecombinantform02crf02aginwestcentralafricamayberelatedtoitsreplicativefitness
AT butelchristelle thepredominanceofhumanimmunodeficiencyvirustype1hiv1circulatingrecombinantform02crf02aginwestcentralafricamayberelatedtoitsreplicativefitness
AT mpoudingolleeitel thepredominanceofhumanimmunodeficiencyvirustype1hiv1circulatingrecombinantform02crf02aginwestcentralafricamayberelatedtoitsreplicativefitness
AT peetersmartine thepredominanceofhumanimmunodeficiencyvirustype1hiv1circulatingrecombinantform02crf02aginwestcentralafricamayberelatedtoitsreplicativefitness
AT arienkevink thepredominanceofhumanimmunodeficiencyvirustype1hiv1circulatingrecombinantform02crf02aginwestcentralafricamayberelatedtoitsreplicativefitness
AT njaiharrf predominanceofhumanimmunodeficiencyvirustype1hiv1circulatingrecombinantform02crf02aginwestcentralafricamayberelatedtoitsreplicativefitness
AT galiyoussef predominanceofhumanimmunodeficiencyvirustype1hiv1circulatingrecombinantform02crf02aginwestcentralafricamayberelatedtoitsreplicativefitness
AT vanhamguido predominanceofhumanimmunodeficiencyvirustype1hiv1circulatingrecombinantform02crf02aginwestcentralafricamayberelatedtoitsreplicativefitness
AT clyberghclaude predominanceofhumanimmunodeficiencyvirustype1hiv1circulatingrecombinantform02crf02aginwestcentralafricamayberelatedtoitsreplicativefitness
AT jenneswim predominanceofhumanimmunodeficiencyvirustype1hiv1circulatingrecombinantform02crf02aginwestcentralafricamayberelatedtoitsreplicativefitness
AT vidalnicole predominanceofhumanimmunodeficiencyvirustype1hiv1circulatingrecombinantform02crf02aginwestcentralafricamayberelatedtoitsreplicativefitness
AT butelchristelle predominanceofhumanimmunodeficiencyvirustype1hiv1circulatingrecombinantform02crf02aginwestcentralafricamayberelatedtoitsreplicativefitness
AT mpoudingolleeitel predominanceofhumanimmunodeficiencyvirustype1hiv1circulatingrecombinantform02crf02aginwestcentralafricamayberelatedtoitsreplicativefitness
AT peetersmartine predominanceofhumanimmunodeficiencyvirustype1hiv1circulatingrecombinantform02crf02aginwestcentralafricamayberelatedtoitsreplicativefitness
AT arienkevink predominanceofhumanimmunodeficiencyvirustype1hiv1circulatingrecombinantform02crf02aginwestcentralafricamayberelatedtoitsreplicativefitness